Active Motif gibt eine exklusive weltweite Vertriebsvereinbarung mit Arima Genomics für fortschrittliche 3D-Genomik-Lösungen bekannt

PartnershipPositive

AI Analysis

Summary

Active Motif announced an exclusive worldwide distribution agreement with Arima Genomics for advanced 3D genomics solutions, expanding Active Motif's genomic research portfolio while supporting Arima's strategic focus on its CARLSBAD clinical diagnostics platform.

Outcome Details

Exclusive worldwide distribution agreement for 3D genomics solutions

Importance:6/10

Sentiment:

0.60

partnershipdistributiongenomicsexclusive agreement

Related Companies

$ACTI.ST

Read the original article

Published by PR Newswire Biotech on July 7, 2026 2:12 AM

Read Original